文献速递妇科生殖医学

保留生育功能手术治疗非上皮性卵巢癌:一项前瞻性全国人群队列研究的肿瘤学与生殖结局

Fertility-sparing surgery for treatment of non-epithelial ovarian cancer: Oncological and reproductive outcomes in a prospective nationwide population-based cohort study.
PubMed 文献 · Gynecol Oncol · 2019-09-04

瑞典全国前瞻性队列纳入2008至2015年73例18-40岁I期非上皮性卵巢癌患者,78%(57例)接受保留生育功能手术,5年总生存率98%,保留生育功能手术与根治性手术的总生存和无进展生存无统计学差异,保留生育功能术后11例自然分娩13名健康婴儿,12%接受辅助生殖技术治疗。

要点

  • 保留生育功能手术治疗I期非上皮性卵巢癌与根治性手术相比总生存和无进展生存无统计学差异。
  • 全队列5年总生存率98%,保留生育功能手术后11例自然分娩13名健康婴儿。
  • 保留生育功能手术后12%(7例)因不孕接受辅助生殖技术治疗。

核心结论

  • 在年轻早期非上皮性卵巢癌女性中,保留生育功能手术的肿瘤学结局不劣于根治性手术,两组预后均良好,总生存率98%。
  • 保留生育功能手术者自然生育力得以维持,仅12%需要辅助生殖技术治疗。

研究设计与样本

  • 前瞻性全国人群队列研究,利用瑞典妇科癌症质量登记处识别2008至2015年18-40岁、I期非上皮性卵巢癌且接受保留生育功能手术或根治性手术的全部女性,共73例。
  • 采用Kaplan-Meier法比较无进展生存和总生存率。
  • 从国家辅助生殖质量登记处(Q-IVF)和瑞典医学出生登记处提取保留生育功能手术后的辅助生殖技术治疗和产科结局数据。

主要发现

  • 研究期间73例18-40岁女性诊断为I期非上皮性卵巢癌,78%(57例)接受保留生育功能手术。
  • 无论手术方式,5年总生存率为98%。
  • 保留生育功能手术与根治性手术的总生存和无进展生存率无统计学差异。
  • 复发在根治性手术组更常见:根治性手术组12.5%(2/16) vs 保留生育功能手术组3.5%(2/57)。
  • 保留生育功能手术后11例女性分娩13名健康儿童(均为自然受孕);队列中12%(7例)发生不孕并接受辅助生殖技术治疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the oncologic outcome of women who underwent fertility-sparing surgery (FSS) vs. radical surgery (RS) for treatment of NEOC in a prospective, nationwide, population-based study and report on the reproductive outcomes in women after FSS. METHODS: Using the Swedish Quality Register for Gynecological Cancer, we identified all women ages 18-40 treated with either FSS or RS for stage I NEOC between 2008 and 2015. Progression-free survival (PFS) and overall survival (OS) rates were compared using the Kaplan-Meier method. Data on use of assisted reproductive technology (ART) treatments and obstetrical outcomes after FSS were extracted from the National Quality Register for Assisted Reproduction (Q-IVF) and the Swedish Medical Birth Register. RESULTS: During the study period, 73 women ages 18-40 received a stage I NEOC diagnosis. The majority, 78% (n = 57), underwent FSS. The 5-year OS rate, regardless of surgical approach, was 98%. There were no statistical differences between OS and PFS rates in women treated with FSS, compared to RS. Recurrences were more common after RS than FSS: 12.5% (2/16) vs. 3.5% (2/57), respectively. Following FSS, 11 women gave birth to 13 healthy children (all conceived naturally). Additionally, 12% of the women in the cohort developed infertility and received ART treatment (n = 7). CONCLUSION: FSS is not associated with worse oncologic outcomes than RS in young women with early stage NEOC. The prognosis was excellent in both groups, with an OS of 98%. Natural fertility was maintained in women treated with FSS, only 12% required ART treatment.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Johansen G, Dahm-Kähler P, Staf C, et al. Fertility-sparing surgery for treatment of non-epithelial ovarian cancer: Oncological and reproductive outcomes in a prospective nationwide population-based cohort study. Gynecol Oncol. 2019. PMID: 31493900. doi:10.1016/j.ygyno.2019.08.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。